Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D53CMU
|
|||
Drug Name |
Methylselenocysteine
|
|||
Synonyms |
Se-methylselenocysteine; 26046-90-2; (R)-2-Amino-3-(methylselanyl)propanoic acid; 3-(Methylseleno)-L-alanine; Se-Methyl-L-selenocysteine; L-Alanine, 3-(methylseleno)-; Selenium-methylselenocystine; Se-Methyl-seleno-L-cysteine; UNII-TWK220499Z; CHEBI:27812; TWK220499Z; Se-methylseleno-L-cysteine; Se-(Methyl)selenocysteine hydrochloride; (2R)-2-amino-3-methylselanylpropanoic acid; Se-methylseleno-L-cysteine, 98%; Selenomethylselenocysteine; CCRIS 5465; Selenomethyl selenocysteine; Methylseleno-L-cysteine; L-Se-methylselenocysteine; C4H9NO2Se; L-methylselenocysteine; methyl-L-selenocysteine; Cysteine, seleno-methyl-; Lopac0_000799; 3-(Methylselanyl)-L-alanine; CHEMBL62382; SCHEMBL420015; Se-(Methyl)seleno-L-cysteine; L-Selenomethylcysteine 0.5% Tr; 2218AB; ANW-64816; MFCD00800565; AKOS016005152; 2-Amino-3-methylselenyl propionic acid; CCG-204883; DB12697; SDCCGSBI-0050776.P002; NCGC00162258-01; NCGC00162258-02; HY-114245; CS-0080570; (2R)-2-amino-3-(methylselanyl)propanoic acid; C05689; J-016235; Q21099600
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Breast cancer [ICD-11: 2C60-2C65; ICD-10: C50, C79.51] | Clinical Trial | [1] | |
Prostate cancer [ICD-11: 2C82.0; ICD-9: 185] | Clinical Trial | [1] | ||
Structure |
Download2D MOL
|
|||
Formula |
C4H9NO2Se
|
|||
Canonical SMILES |
C[Se]CC(C(=O)O)N
|
|||
InChI |
1S/C4H9NO2Se/c1-8-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1
|
|||
InChIKey |
XDSSPSLGNGIIHP-VKHMYHEASA-N
|
|||
CAS Number |
CAS 26046-90-2
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:27812
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01611038) Methylselenocysteine Effects on Circadian Rhythm. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.